"Seeing the before and after endoscopic videos from patients in Cohort 1 is the most encouraging support of Brilacidin’s potential for treating IBD. I am proud to say that to date, every patient in this trial has benefited from their Brilacidin treatment.”
Actual scientific fact that CANNOT be spun as negative. PROOF that Brilacidin-UP improved their condition, in the lowest dose cohort.
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links